Delivery Order SPE2DB22D1017-SPE2DB25FG4FC

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,148.34, is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 2, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,518.52 Firm Fixed Price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has a performance period through May 7, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,398.31, is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 2, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,896.72 firm fixed-price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,636.75 and is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of June 13, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $5,464.86 firm-fixed-price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, including a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,407.57 firm fixed-price delivery order is for the supply of 4568239242 MESALAMINE DR 1.2 GM TABLET 120S. The contract has an ultimate completion date of May 14, 2025. This award is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,423.89 firm fixed-price delivery order is for the supply of 4,568,249,081 units of the prescription medication Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $3,875.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for MESALAMINE DR 1.2 GM TABLET 120S, a medication used to treat gastrointestinal conditions. The contract has a firm fixed-price pricing type and an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,261.56 firm fixed-price delivery order is for the provision of Mesalamine ER 0.375 gram capsules, a pharmaceutical product used to treat certain gastrointestinal conditions. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the primary...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG4FC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,477.75 firm-fixed-price delivery order is for MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The award has a completion date of June 5, 2025.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside.

Generated 9/3/25, 9:52 AM